
Sign up to save your podcasts
Or
A vaccine which has shown in a clinical trial to be 90% effective against Covid 19 has been widely welcomed. But what does it mean and how was it worked out? Although experts and politicians urge caution, how excited can we be about the results of this trial of the vaccine developed by Pfizer and BioNTech? Tim Harford explores what we know about this new vaccine candidate with Jennifer Rogers, vice president of the Royal Statistical Society in the UK, and she also works for Phastar, a consultancy which specialises in analysing clinical trials. Presenter: Tim Harford Producer: Charlotte McDonald
4.7
764764 ratings
A vaccine which has shown in a clinical trial to be 90% effective against Covid 19 has been widely welcomed. But what does it mean and how was it worked out? Although experts and politicians urge caution, how excited can we be about the results of this trial of the vaccine developed by Pfizer and BioNTech? Tim Harford explores what we know about this new vaccine candidate with Jennifer Rogers, vice president of the Royal Statistical Society in the UK, and she also works for Phastar, a consultancy which specialises in analysing clinical trials. Presenter: Tim Harford Producer: Charlotte McDonald
5,425 Listeners
368 Listeners
7,646 Listeners
526 Listeners
342 Listeners
36 Listeners
2,123 Listeners
283 Listeners
2,076 Listeners
1,044 Listeners
240 Listeners
398 Listeners
295 Listeners
764 Listeners
83 Listeners
478 Listeners
620 Listeners
367 Listeners
136 Listeners
321 Listeners
2,966 Listeners
78 Listeners
602 Listeners
1,002 Listeners
2,999 Listeners
538 Listeners
609 Listeners
120 Listeners
126 Listeners
275 Listeners
27 Listeners
77 Listeners
4 Listeners